AI-driven relapse predictions could be a tool in the fight against opioid addiction. Find out how researchers used smartphone data to forecast potential drug relapses.
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) unveiled three new advanced deep learning image processing and reconstruction solutions as a part of its Effortless Recon DL portfolio at the ...
Unlock the future of health with Dr. Anasuya Roy's groundbreaking AI-powered micronutrient system revealed at TiEcon Delhi ...
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
A new artificial intelligence approach developed by investigators in Cedars-Sinai's Los Angeles-based Smidt Heart Institute has been shown to detect abnormal heart rhythms associated with atrial ...
Indivi and Clouds of Care, two independent TechBio companies, today announced a strategic partnership to advance the use of precision medicine tools in early-phase neuroscience drug development, ...
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the ...
Deep learning (DL) is a type of artificial intelligence (AI) that utilizes artificial neural networks (ANNs) to process data through two or more layers, each of which can recognize complex features of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback